Electronic Cigarettes: Potential Harm to Respiratory Health

May.30.2022
Electronic Cigarettes: Potential Harm to Respiratory Health
A new study by USC suggests that e-cigarette use may not be much safer than traditional smoking, and can still lead to respiratory problems.

A new study published by the University of Southern California in Los Angeles has found that using e-cigarettes may not actually be significantly safer than smoking traditional cigarettes and can still lead to serious respiratory problems for both smokers and those around them.

 

Electronic cigarettes are often marketed as a healthier alternative to traditional cigarettes because they do not contain tar, which is a primary ingredient in traditional cigarettes that can harm lung health. However, they still contain nicotine, an addictive ingredient found in cigarettes, as well as many other chemicals that combine to form an aerosol that users inhale.

 

As research around the use of e-cigarettes continues to grow, medical experts are consolidating a comprehensive report on the potential harms caused by e-cigarettes. A new peer-reviewed study by the Department of Population and Public Health Sciences at the University of Southern California in Los Angeles examines the effects of second-hand smoke from e-cigarettes.

 

Research question: Does being exposed to secondhand electronic smoke cause respiratory symptoms?

 

A study titled "The Effects of In-Home E-Cigarette Secondhand Smoke Exposure on Respiratory Symptoms in Young Adults" aims to investigate the potential association between exposure to secondhand nicotine electronic cigarettes and adverse respiratory outcomes among young individuals.

 

To evaluate their objectives, a research team led by Professor Talat Islam studied six years of data from 2014 to 2019 on the incidence of bronchitis and respiratory distress in high school students aged 17-18. A total of 2090 students participated in the study.

 

Research process.

 

In the first phase of the study conducted in 2014, students completed a survey detailing their exposure to electronic cigarette vapor and their medical history. Subsequently, three more follow-up surveys were completed in 2015, 2017 and 2018 over the next few years.

 

However, among the initial 2,090 students, 23% left the study after completing high school and did not participate in any follow-up evaluations. Nevertheless, the researchers pointed out that there was no significant difference in the occurrence of bronchial symptoms and respiratory distress associated with secondhand nicotine e-cigarette use between those who left the study early and those who stayed.

 

The respiratory symptoms measured are those associated with bronchitis, such as wheezing and shortness of breath experienced within the past 12 months. Participants who reported experiencing bronchitis within the past year, including a persistent cough for three consecutive months or congestion without a cold, were determined to have symptoms of bronchitis.

 

The symptoms of wheezing are based on chest wheezing in the past year, while shortness of breath is based on difficulties breathing when walking quickly on flat ground or up a small incline.

 

At each stage of the study, detailed information about secondhand vapor from electronic cigarettes and secondhand smoke from traditional cigarettes is collected from participants. The definition of exposure to nicotine electronic "secondhand smoke" is based on the participants' situation, meaning anyone other than themselves in their household using electronic cigarettes or similar devices.

 

After completing data collection for their research, the team turned their focus to statistical analysis. At each stage of the study, they evaluated the association between exposure to secondhand nicotine from e-cigarettes and respiratory symptoms, making necessary adjustments and taking into account whether participants were smokers themselves to ensure the results were not skewed.

 

Research findings

 

After analyzing the data, a research team from the University of Southern California found that the prevalence of exposure to secondhand nicotine from electronic cigarettes has increased from 11.7% in 2014 to 15.6% in 2018.

 

A higher prevalence of asthma and bronchial inflammation symptoms was observed among study participants. The prevalence of asthma symptoms increased from 12.3% to 14.9%, while that of bronchial inflammation symptoms increased from 19.4% to 26.0%. However, the occurrence of shortness of breath did not show any notable trend over time.

 

According to the data, individuals who have been exposed to secondhand nicotine smoke display a noticeable increase in respiratory symptoms compared to those who have not been exposed. Participants who reported exposure to secondhand smoke were found to have a 40% higher likelihood of developing symptoms of bronchitis compared to participants who were not exposed to electronic cigarettes. Additionally, the possibility of experiencing shortness of breath symptoms was 53% higher among those who had been exposed to secondhand smoke.

 

The researchers stated that, to their knowledge, this is the first extended report based on research that demonstrates the impact of inhaling second-hand nicotine from e-cigarettes on respiratory symptoms in young individuals.

 

Source: THE JERUSALEM POST

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
European Ombudswoman Teresa Anjinho has opened an inquiry into how the European Commission’s Directorate-General for Trade handles interactions with the tobacco industry. The case follows a complaint from a civil society organisation that alleges regular, unnecessary and non-transparent contacts between DG TRADE and tobacco industry representatives, raising questions over compliance with the EU’s obligations under the WHO Framework Convention on Tobacco Control. The inquiry remains ongoing, and the Ombudswoman has not reached any finding of maladministration.
Aug.24
Japan Health Ministry Cites Limited Evidence in Decision Not to Tighten Heated Tobacco Rules
Japan Health Ministry Cites Limited Evidence in Decision Not to Tighten Heated Tobacco Rules
Japan’s health ministry has proposed not tightening regulations on heated tobacco products to the same level as cigarettes as part of a review of passive smoking measures, with an expert panel broadly agreeing with the proposal, Jiji Press reported.
Jul.10
PMI Expands IQOS and VEEV Presence at Frankfurt Airport Through Travel Retail Pop-Ups
PMI Expands IQOS and VEEV Presence at Frankfurt Airport Through Travel Retail Pop-Ups
According to The Moodie Davitt Report, PMI Global Travel Retail and Frankfurt Airport Retail have launched new IQOS and VEEV retail spaces at Frankfurt Airport. The installations, located inside and outside duty-free areas, showcase IQOS heated tobacco products and VEEV e-vapor products through product education, consumer interaction and brand experiences. Frankfurt Airport Retail, operated by Fraport Group and Gebr. Heinemann, manages key retail activities at Frankfurt Airport. The initiative follows PMI’s broader strategy of expanding smoke-free products through global travel retail channels. PMI has previously introduced VEEV products across multiple European airports while continuing to expand IQOS and VEEV availability in international markets.
Jul.17
Pennsylvania Updates ENDS Certification List as Chinese-Linked Manufacturers Enter State Review
Pennsylvania Updates ENDS Certification List as Chinese-Linked Manufacturers Enter State Review
Pennsylvania’s June 26 Pending ENDS Certifications list includes 23 manufacturers under review, including Shenzhen Smoore, Shenzhen IVPS, YME Technology and China-linked Boulder International. The list shows state-level vape regulation moving beyond retail brands toward manufacturer-based market access alongside FDA oversight.
Regulations
Jul.06 by 2Firsts Perspectives
JT’s Ploom Volumes Rise 43.5% as Cigarettes Anchor Its Transition
JT’s Ploom Volumes Rise 43.5% as Cigarettes Anchor Its Transition
JT’s Ploom heated-tobacco volumes rose 43.5% in the first half of 2026, while combustibles still represented about 97% of its tobacco volume and remained the main earnings base. In Japan, reduced-risk products now account for 48.7% of industry shipments, shifting competition from category adoption towards brand share, pricing and consumer retention. JT’s results offer a revealing case of a traditional tobacco company pursuing a prolonged, dual-track transformation.
JTI
Jul.30
South Korea Vape Strategies Diverge as BAT Reconsiders Exit and PMI Takes VEEV to About 14,000 Stores
South Korea Vape Strategies Diverge as BAT Reconsiders Exit and PMI Takes VEEV to About 14,000 Stores
BAT Rothmans says it previously considered exiting South Korea's vaping market because of competitive pressure from unregulated products, but is now reassessing conditions following changes to the country's nicotine regulatory framework. Vuse and other BAT vaping products remain available through existing distribution channels. The statement followed a South Korean media report that interpreted BAT's broader withdrawal from selected Vapour markets as a full exit from South Korea. Meanwhile, Philip Morris International launched VEEV inPRIME in the country in June and began expanding distribution to around 14,000 convenience stores and other retail channels in July. The contrasting moves highlight differing investment strategies as South Korea's regulated vaping market evolves.
Aug.14